Table 1.
Peptide | Target | Experimental System | Reference |
---|---|---|---|
CBZ-D-Phe-L-Phe-Gly | gp41 fusion peptide | Cell–cell fusion; infection | [18] |
gp41 N-terminal hexapeptide | gp41 fusion peptide | gp120/gp41 pseudo-virus fusion | [19] |
aa 81–92 of CD4 | gp120 | Cell–cell fusion; infection | [20] |
CD4 CDR-3-like domain | gp120 | Cell–cell fusion | [21] |
V3 loop eight-branched peptide | gp120 | HIV infection | [22] |
DP-178 | gp41 NHR | Cell–cell fusion | [23,24] |
PEG-C34 | gp41 NHR | Cell–cell fusion | [25] |
Cholesterol-C34 | gp41 NHR | Infection | [26] |
PIE12-trimer | gp41 NHR hydrophobic pocket | HIV-1 and pseudo-type infection | [27] |
* Abbreviation: NHR, N-terminal heptad repeat.